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IN VITRO SENSITIVITY SCREENING
SYSTEM FOR HUMAN CANCERS TO
DRUGS AND HYPERTHERMIA (420C).
J. A. DICKsoN and M. SUZANGAR. Cancer
Research Unit, Department of Clinical
Biochemistry, University of Newcastle upon
Tyne.
Approximately 75% of a series ofover200
human solid neoplasms were sensitive to
either hyperthermia (42°C) or cytotoxic
drug(s), or a combination of these, as defined
by a 30% or greater inhibition of respiration
and/or anaerobic glycolysis brought about by
the agent in fresh and/or cultured tumour.
The inhibition was paralleled by decreased
radioactive precursor incorporation into
DNA, RNA and protein by the tumour slices.
In a solid Yoshida rat tumour there was close
correlation between the biochemical response
in vitro to heat and drugs and the in vivo
response of the tumour. Sensitivity in this
system is taken to indicate a drug and/or
heat responsive cell population within the
tumour. The extent to which such a result
predicts patient response will depend upon
the existence or emergence of resistant cells
inthetumour in vivo, and on the sensitivity of
metastatic cells.
THE NATURE OF THE RESISTANCE
TO METHYLENE DIMETHANE SUL-
PHONATE IN THE YOSHIDA
SARCOMA. B. W. Fox and M. Fox.
Paterson Laboratories, Christie Hospital,
Manchester.
In order to define the biochemical change
responsible for the induction of resistance
towards a potent antitumour agent methyl-
ene dimethane sulphonate, tumours in vivo
have been transferred to in vitro conditions in
which they grow continuously as single cell
suspension cultures. Both resistant and
sensitive cells are maintained in vitro anc
cross-resistant studies indicate that the two,
cell lines show a similar wide difference in"
sensitivity to ultraviolet radiation and sul-
phur mustard, but no difference to x-rays
and methyl methane sulphonate. This pat-
tern of sensitivity implies a deficiency on the
part of the sensitive cells of a step in the
repair of damage produced in the DNA by
u.v. or MDMS but not by x-rays and MMS.
This has been shown to be the case and the
Yoshida sensitive line thus resembles the
human repair deficiency disease ofxeroderma
pigmentosum.
EVIDENCE FOR THE ACTIVE INTER-
MEDIATE IN CYCLOPHOSPHAMIDE
METABOLISM. P. J. Cox (introduced by
T. A. CONNORS). Chester Beatty Research
Institute, London.
Two ethyl derivatives of an intermediate
ofcyclophosphamide metabolism, 4-hydroxy-
cyclophosphamide, have now been isolated
and identified, by T.L.C. and mass spectro-
metry, in extracts of microsomal incubations
with[32P]-cyclophosphamide. Bytheuseofa
cell culture bioassay technique, these deriva-
tives have been shown to be highly toxic to
Walker ascites cells. The toxicities of
various previously identified metabolites
were assessed in an in vitro bioassay system.
The results were consistent with the view that
the formation of4-hydroxycyclophosphamide
is the important step in the activation of
cyclophosphamide, as this metabolite can
break down spontaneously to the active
alkylating agent, phosphoramide mustard
[N,N-bis(2-chloroethyl) phosphorodiamidic
acid], and acrolein. 4-hydroxycyclophos-
phamide has been tentatively inferred as the
hydrolysis product of both ethyl derivatives
isolated, but attempts to extract more than
minute quantities ofthe free metabolite from
in vitro microsomal incubations have been
unsuccessful.
ENZYME ACTIVATED ALKYLATING
AGENTS. C. R. BALL, J. A. DOUBLE and
J. GOODBAN. Department of Cancer Re-
search, University of Leeds.
Recently Ross and co-workers (Bukhari,
Everett and Ross, Biochem. Pharmac., 1971,
21, 963) published the syntheses of 3 con-
jugates of p-hydroxyaniline mustard which
they suggested might be selective for tumours
with high levels of ,B-glucuronidase, phos-
phatase and sulphatase. The 0-glucuronide,
0-phosphate and 0-sulphate respectively
were expected to be deconjugated in vivo by
the appropriate enzymes. High enzyme
activity in a particular tumour could lead to
selectivity of action due to the greater release
of the rapidly reacting p-hydroxyaniline
mustard in the tumour than elsewhere.
We have determined the ability of the
appropriate enzymes to utilize these drugs
(kindly supplied by Professor Ross) as sub-